Samil Pharmaceutical Co.,Ltd (KRX:000520)

South Korea · Delayed Price · Currency is KRW

11,290

+200 (1.80%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceutical	219.70B	196.35B	179.68B	134.25B	123.00B
Pharmaceutical Growth	11.89%	9.28%	33.84%	9.14%	1.56%
Total	219.70B	196.35B	179.68B	134.25B	123.00B
Total Growth	11.89%	9.28%	33.84%	9.14%	1.56%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	217.52B	194.93B	178.83B	133.73B	121.26B
South Korea Growth	11.59%	9.00%	33.72%	10.28%	0.92%
Export	2.18B	1.42B	842.66M	514.49M	1.73B
Export Growth	53.48%	68.47%	63.78%	-70.33%	84.01%
Total	219.70B	196.35B	179.68B	134.25B	123.00B
Total Growth	11.89%	9.28%	33.84%	9.14%	1.56%

Source: S&P Global Market Intelligence.